Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis.

Menopause. 2018 Feb 16. doi: 10.1097/GME.0000000000001080. [Epub ahead of print].

McClung MR, Harvey NC, Fitzpatrick LA, Miller PD, Hattersley G, Wang Y, Cosman F.

https://www.ncbi.nlm.nih.gov/pubmed/29462094